Skip to main navigation Skip to search Skip to main content

Tumor-specific surface marker–independent targeting of tumors through nanotechnology and bioorthogonal glycochemistry

  • Hyesun Hyun
  • , Bo Sun
  • , Mostafa Yazdimamaghani
  • , Albert Wielgus
  • , Yue Wang
  • , Stephanie Ann Montgomery
  • , Tian Zhang
  • , Jianjun Cheng
  • , Jonathan S. Serody
  • , Andrew Z. Wang
  • University of North Carolina at Chapel Hill
  • University of Arizona
  • Department of Pharmacology
  • Department of Pathology and Laboratory Medicine
  • University of Texas Southwestern Medical Center
  • Westlake University
  • Department of Emergency Medicine

Research output: Contribution to journal › Article › peer-review

Original languageEnglish
Article numbere184964
JournalJournal of Clinical Investigation
Volume135
Issue number9
DOIs
StatePublished - May 1 2025
Externally publishedYes

ASJC Scopus Subject Areas

  • General Medicine

Keywords

  • Animals
  • Mice
  • Female
  • Nanoparticles/chemistry
  • Cell Line, Tumor
  • Humans
  • Biomarkers, Tumor/immunology
  • Melanoma, Experimental/immunology
  • Nanotechnology
  • Mice, Inbred C57BL
  • Mice, Inbred BALB C
  • CD8-Positive T-Lymphocytes/immunology
  • Mammary Neoplasms, Experimental/immunology

Fingerprint

Dive into the research topics of 'Tumor-specific surface marker–independent targeting of tumors through nanotechnology and bioorthogonal glycochemistry'. Together they form a unique fingerprint.

Cite this